Five years of PCSK9i - Lessons from practice: Which patients benefit most?
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunitiesIntroduction: PCSK9i & LDL-c - Guidelines, Practice & Innovation
Prof. John Kastelein, MD
- PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunitiesTime to reduce implementation gaps of lipid-lowering therapy
Prof Kausik Ray
- PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunitiesOne year after the new ESC/EAS dyslipidemia guidelines
Prof. François Mach, MD
